Safety Profile Overview
TNF receptor fusion protein for RA, psoriasis, and ankylosing spondylitis. One of the original biologics with extensive long-term safety data.
Generic Name
etanercept
Brand Names
Enbrel
Therapeutic Class
TNF Inhibitor
Manufacturer
Amgen
What Pharma Signal Tracks for Enbrel
- Adverse Events (FAERS) — All FDA Adverse Event Reporting System reports mentioning Enbrel, including serious outcomes, hospitalizations, and deaths.
- FDA Recalls — Class I, II, and III recalls, market withdrawals, and safety alerts related to Enbrel products.
- Label Changes — Boxed warning additions, new contraindications, dosing modifications, and safety-related labeling supplements.
- Risk Score — Composite risk score (0–100) combining adverse event rates, recall history, and label severity with explainable breakdown.
- Pharmacovigilance Signals — Proportional Reporting Ratio (PRR) and Reporting Odds Ratio (ROR) analysis detecting disproportionate adverse reactions.
- Trend Analysis — Monthly time series with anomaly detection for emerging safety signals.
Data Disclaimer: Pharma Signal aggregates data from the FDA Adverse Event Reporting System (FAERS) and other public regulatory sources. FAERS reports do not establish causation. Report counts may reflect prescription volume rather than relative safety. Always consult healthcare professionals for medical decisions.
Get Enbrel Safety Data via API
One API call returns adverse events, risk scores, recalls, and pharmacovigilance signals for Enbrel.
curl "https://api.pharma-signal.com/drug/safety/enbrel" \ -H "X-API-Key: your_key" # Returns risk score, adverse event counts, # serious/death rates, recalls, and signals
Related Safety Intelligence
Pharma Signal provides comparative analysis across therapeutic classes. Compare Enbrel against other TNF Inhibitor drugs, or explore the full manufacturer portfolio for Amgen.
- Head-to-head comparison — Compare up to 5 drugs side by side on all safety metrics.
- Therapeutic class benchmarking — See how Enbrel ranks within TNF Inhibitor on serious event rates.
- Company portfolio risk — View all drugs from Amgen with aggregate risk exposure.
- AI analyst briefs — Get a natural-language safety assessment combining all data sources.